Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Cancer Genetic Markers of Susceptibility (CGEMS): Contribution of Breast Cancer Cases and Controls from PLCO Cancer Screening Trial

Datasets


Site: Misc

Inclusion Criteria:

  • All I-Arm Females
  • Supplemental Questionnaire
  • No prior history of any cancer prior to SQX
  • No confirmed or reported cancers
  • No rare cancers
  • Subjects are dead
  • No oral contraceptive use (BQ)
  • No current hormone use (SQX and BQ)
  • Has Biochemical Consent
  • Has Serum and Plasma Available
  • Has Perfect Serum and Plasma Available
  • Has Perfect T4/5 Serum and Plasma Available
  • Has Serum and Plasma Available at the same study year (Eligible)
  • Randomly selected 30 (Selected)

Match Ratio: Not Applicable

Match Technique: Not Applicable


Analytes:

  • C-Peptide
  • Insulin-like Growth Factor 1
  • Insulin-like Growth Factor 2
  • Insulin-like Growth Factor Binding Protein 3
  • Leptin

Number of Controls: 30